Culture environment modulates maturation and metabolism of human oocytes

Ruth Roberts1, Stephen Franks and Kate Hardy

Department of Reproductive Science and Medicine, Institute of Reproductive and Developmental Biology, The Wolfson and Weston Research Centre for Family Health, Imperial College, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK


    Abstract
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 Acknowledgements
 References
 
BACKGROUND: The clinical use of oocytes matured in vitro for IVF is increasing, but little is known about the effect of culture conditions on oocyte maturation. METHODS: Denuded immature oocytes identified following superovulation prior to ICSI were individually matured in one of two commercial media: tissue culture medium (TCM) 199 or modified Eagle medium with Earle’s modified salts (MEME). During maturation, depletion of pyruvate and accumulation of lactate in the culture medium were non-invasively measured. RESULTS: Maturing oocytes took up pyruvate (20–30 pmol/oocyte/h) and produced lactate (2–10 pmol/oocyte/h). Oocytes matured faster in MEME, with significantly more oocytes reaching metaphase II by 24 h after oocyte retrieval compared with TCM 199 (P = 0.03). The oocytes that matured more quickly in MEME had significantly lower lactate production than oocytes that matured more slowly (P = 0.02). In TCM 199, pyruvate uptake by rapidly maturing oocytes was lower than by slowly maturing oocytes (P = 0.05). During the second incubation, from 24 to 48 h post-oocyte retrieval, pyruvate uptake in MEME was 30% lower than in TCM 199 (P = 0.007). Pyruvate uptake and lactate production differed depending on the stage of nuclear maturation: pyruvate uptake and lactate production were greater during germinal vesicle breakdown than during polar body extrusion in MEME (P < 0.05). CONCLUSIONS: We have shown that: (i) pyruvate is a major energy source during oocyte maturation; (ii) the composition of the culture medium can affect the rate of maturation; and (iii) the culture medium and stage of nuclear maturation can affect pyruvate uptake and lactate production.

Key words: IVF/IVM/lactate/medium/pyruvate


    Introduction
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 Acknowledgements
 References
 
In-vitro maturation (IVM) of oocytes from small antral follicles could potentially provide increased numbers of oocytes for IVF, reducing the need for exogenous gonadotrophin treatment and offering an alternative to superovulation. In humans there are several such follicles present in the early follicular phase, the majority of which regress by atresia in the few days before ovulation. Pregnancies and live births have been achieved following maturation and fertilization in vitro of oocytes retrieved from small antral follicles (Trounson et al., 2001Go), but clinical pregnancy rates are generally lower than those achieved using standard IVF.

A suboptimal environment for maturation in vitro is one of many factors that could account for the low pregnancy rates. Studies in cows and mice have shown that a variety of commercially available culture media have widely differing effects on spontaneous nuclear maturation and subsequent preimplantation development following IVF (van de Sandt et al., 1990Go; Rose and Bavister, 1992Go). Indeed, in domestic species, the exposure of oocytes and early embryos to certain culture conditions can have profoundly deleterious effects on preimplantation, fetal and post-natal development, resulting in a spectrum of abnormalities collectively referred to as ‘large offspring syndrome’ (Young et al., 1998Go; McEvoy et al., 2001Go). It has been proposed that genesis of these abnormalities may involve cellular stress responses to culture conditions and, consequently, disturbances in metabolism and gene expression which result in abnormal development (Leese et al., 1998Go). In preimplantation embryos, gene expression and genomic imprinting is altered under different culture conditions (Ho et al., 1995Go; Doherty et al., 2000Go; Niemann and Wrenzycki, 2000Go; Khosla et al., 2001Go). A wide variety of culture media, which may be supplemented with any of a number of gonadotrophins, steroids and growth factors, have been used for the maturation of human oocytes in vitro before fertilization and embryo transfer (Trounson et al., 2001Go). The animal studies described above highlight the need for a greater understanding of both human oocyte maturation and the effects of the maturation environment on subsequent embryo and fetal development.

In vivo, oocytes resume meiosis and undergo nuclear maturation following the LH surge, although fully grown oocytes from many species can mature spontaneously, resuming meiosis following release from the follicle (Pincus and Enzmann, 1935Go; Edwards, 1965Go). A critical part of the maturation process may involve the development and activation of appropriate metabolic pathways as metabolism shifts from involving both granulosa cells and the oocyte within the cumulus–oocyte complex to being oocyte-centred. This shift is important in ensuring the metabolic independence of the oocyte following ovulation and loss of gap junctional communication with surrounding cumulus cells.

Despite increased clinical interest in human IVM over the past decade, little is known about the metabolism of the maturing oocyte, particularly in the absence of surrounding cumulus cells. Pyruvate is produced by cumulus cells (Leese and Barton, 1985Go), and is the major energy source for maturing mouse, cow and cat oocytes (Biggers et al., 1967Go; Steeves and Gardner, 1999aGo; Khurana and Niemann, 2000Go), with minimal metabolism of glucose (Rieger and Loskutoff, 1994Go; Spindler et al., 2000Go). Energy substrates have also been shown to play an important role in modulating oocyte maturation by interacting with meiotic inhibitors such as hypoxanthine (Fagbohun and Downs, 1992Go; Downs and Mastropolo, 1994Go).

Superovulation techniques aim to maximize oocyte maturation in vivo; however, 5–15% of aspirated oocytes remain at the germinal vesicle (GV) stage at the time of oocyte collection (Janssenswillen et al., 1995Go; Farhi et al., 1997Go). Why these oocytes fail to complete nuclear maturation remains unknown; the follicles may be resistant, or less responsive, to hormonal stimulation (Farhi et al., 1997Go), a proportion may be atretic (Goud et al., 1998Go) or they may simply be at an earlier developmental stage (Kim et al., 2000Go). The latter is the most likely scenario as, with further culture, a cohort will complete nuclear maturation, and can be successfully fertilized and will initiate embryonic development (Janssenswillen et al., 1995Go; Farhi et al., 1997Go; Goud et al., 1998Go; Haberle et al., 1999Go; Kim et al., 2000Go). Pregnancies and live births have been achieved using such in-vitro matured oocytes (Nagy et al., 1996Go; Edirisinghe et al., 1997Go; Tucker et al., 1998Go). Oocytes that remain immature at the time of oocyte collection are not suitable for ICSI. The exposure of these oocytes to hCG before oocyte retrieval, followed by the removal of cumulus cells to confirm maturity prior to ICSI, will promote resumption of meiosis. These denuded oocytes can be used to study the effect of culture media on the completion of oocyte maturation and the accompanying changes in metabolic requirements.

The aims of this study were to: (i) evaluate whether the basic culture medium alone, in the absence of hormones and growth factors, could influence rates of human oocyte maturation; (ii) assess non-invasively, for the first time, pyruvate uptake and lactate production by oocytes as they complete nuclear maturation in vitro; and (iii) ascertain whether the composition of the culture medium affects oocyte metabolism. To achieve these aims, we matured individual GV stage oocytes in one of two commercial culture media commonly used for oocyte maturation: tissue culture medium (TCM) 199 and modified Eagle medium with Earle’s modified salts (MEME). During maturation we non-invasively measured the depletion of pyruvate and the accumulation of lactate in the culture medium.


    Materials and methods
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 Acknowledgements
 References
 
Source of human oocytes
Immature oocytes were donated to research, with informed consent, from 44 women undergoing cycles of ICSI. Following pituitary desensitization with a GnRH analogue (Buserelin; Hoechst, Middlesex, UK), the women underwent ovarian stimulation using recombinant FSH (Puregon; Organon, Cambridge UK, or Gonal F; Serono, Welwyn Garden City, UK). When the ovaries contained three or more follicles >17 mm in diameter and the estradiol levels were >3500 pmol/l, 10 000 IU of hCG (Profasi; Serono) was administered and transvaginal oocyte retrieval took place 36–38 h later. Oocytes were denuded of cumulus cells by repeated pipetting in an 80 IU/ml hyaluronidase solution (Sigma, Poole, UK) and metaphase II oocytes were selected for ICSI. Sibling and single immature oocytes that were still at the GV stage were initially cultured either in Earle’s Balanced Salt Solution (Life Technologies, Paisley, UK) (Dawson et al., 1995Go), Sydney IVF Fertilization medium (Cook UK Ltd, Letchworth, Herts, UK) or Universal IVF medium (Medicult UK Ltd, Redhill, Surrey, UK). These oocytes were donated to research on the afternoon of oocyte retrieval (day 0) and sibling oocytes were randomly allocated to one of two experimental media (see below). Only morphologically normal oocytes were included in the study. Oocytes with uneven, granular cytoplasm, cytoplasmic vacuoles or evidence of degeneration were excluded. Oocytes were classified as being at: (i) GV stage if the nuclear membrane remained intact and was clearly visible by light microscopy; (ii) metaphase I if there was no visible nuclear membrane; or (iii) metaphase II following extrusion of the first polar body.

IVM
Two commercially available media were used for further culture of the immature oocytes, TCM 199 (Gibco BRL, Paisley, UK) and MEME (Gibco) (Table IGo). Both media contain inorganic salts, glucose and essential amino acids and are supplemented with 0.4% (v/v) human serum albumin (Zenalb 20; Bio Products Laboratory, Elstree, Herts, UK), 0.47 mmol/l sodium pyruvate (Sigma), 83.2 IU/ml penicillin (Sigma) and 0.075 mg/ml streptomycin. TCM 199 is more complex than MEME, containing, in addition, DNA and RNA precursors and a wider range of non-essential amino acids and vitamins.


View this table:
[in this window]
[in a new window]
 
Table I. Composition of TCM 199 and MEME
 
Denuded sibling oocytes were randomly and evenly divided between the two culture conditions; single oocytes were randomly distributed to either medium. Oocytes were cultured individually in pre-equilibrated drops of medium overlaid with silicone fluid (Dow Corning 200/50 cs; BDH) in an atmosphere of 5% CO2 in air at 37°C. Initially, oocytes were cultured in drops of ~20 µl (n = 19) until 48 h post-oocyte retrieval. Subsequently oocytes (n = 59) were washed through 3 drops of culture medium before culture in 5 µl drops for analysis of pyruvate uptake and lactate production. Drops were laid down using a positive displacement pipette (SMI digital adjust micro/pettor, accuracy: ±1%; Alpha Laboratories, Eastleigh, Hants, UK). Oocytes were placed in culture on the afternoon of the day of oocyte retrieval, and oocyte maturation was assessed immediately and then again on the mornings of day 1 (24 h post-oocyte retrieval) and day 2 (48 h post-oocyte retrieval). On the morning of day 1, oocytes were moved from the incubation drops to fresh 5 µl incubation drops for culture until the morning of day 2. Oocytes were also photographed at these times.

Measurement of pyruvate uptake and lactate production
Fifty-nine immature ICSI oocytes (which had been completely denuded of cumulus cells) were cultured singly in 5 µl drops of either TCM 199 (n = 26) or MEME (n = 33) overnight from day 0 to day 1 (~17 h), and for a further 24 h in fresh 5 µl drops of the same medium. Similar 5 µl drops of medium alone were incubated alongside the oocyte-containing drops and served as controls. At the end of each culture period, individual 3 µl aliquots of the spent and control drops from the recently terminated culture dishes were diluted with 597 µl of a 5 µmol/l lactate solution (lactate standard; Sigma). Pyruvate uptake and lactate production were measured by analysing the difference between nutrient concentrations in the control and incubation drops as described previously (Hardy et al., 1995Go). The high concentration of glucose in these commercial media precluded the accurate measurement of glucose uptake by single oocytes.

Ethical approval
The study was granted ethical approval by the Research Ethics Committee for Hammersmith, Queen Charlotte’s and Chelsea and Acton Hospitals, and written consent was obtained from all participating patients.

Statistical analysis
{chi}2 and Mann–Whitney U-tests were used for statistical analyses as appropriate. Significance was accepted when P < 0.05.


    Results
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 Acknowledgements
 References
 
Source of oocytes
A total of 636 oocytes were collected from 44 women undergoing a cycle of ICSI; of these, 466 (73.3%) were at the metaphase II stage, 40 (6.3%) at metaphase I, 100 (15.7%) at GV and 30 (4.7%) were degenerate. One hundred denuded immature ICSI oocytes were donated to research, of which 78 were suitable for further maturation in vitro on the basis of the morphological criteria described above. A total of 36 were cultured in TCM 199 and 42 in MEME. Pyruvate uptake and lactate production by 59 of these oocytes were assessed (26 in TCM 199 and 33 in MEME). Five oocytes with persistently adherent cumulus cells were excluded from further analysis. In allocating oocytes to each of the two culture media, there was no statistical difference in patient population with regard to age, peak estradiol levels, follicle diameters at the time of oocyte collection, number of oocytes retrieved and oocyte nuclear stage at the time of aspiration.

IVM
All oocytes were at the GV stage at the time of oocyte retrieval. Those donated to research were available for study on the afternoon of oocyte retrieval, by which time a proportion had already initiated GV breakdown (GVBD). Denuded oocytes were randomly allocated to the two culture media before scoring and retrospective analysis showed that there was no significant difference between the two groups in terms of developmental stage at 6 h. At 24 h post-aspiration, significantly more oocytes had progressed to metaphase II in MEME (55%) than in TCM 199 (28%) (P = 0.03; Figure 1Go). At 48 h post-aspiration, the majority of oocytes had completed nuclear maturation with 74% metaphase II oocytes in MEME compared with 69% in TCM 199 (not significant; Figure 1Go).



View larger version (12K):
[in this window]
[in a new window]
 
Figure 1. Proportion of oocytes at the germinal vesicle (GV), metaphase I (Met I) and metaphase II (Met II) stages of maturation at 24 h (left panel) and 48 h (right panel) post-oocyte retrieval, after culture in TCM 199 ({square}, n = 36) and MEME ({blacksquare}, n = 42).

 
Pyruvate uptake and lactate production
Pyruvate uptake and lactate production by individual denuded ICSI oocytes were measured during two successive incubations over a 48 h period (Figure 2Go). During the first incubation, some oocytes completed maturation (fast maturers), while some only reached metaphase I (slow maturers) during this initial incubation. In TCM 199, pyruvate uptake for fast maturers was lower than for slow maturers (P = 0.05) (Figure 2Go).



View larger version (24K):
[in this window]
[in a new window]
 
Figure 2. Pyruvate uptake and lactate production (pmol/oocyte/h) by oocytes at metaphase I (Met I) and metaphase II (Met II) stages at the end of the first incubation period (left panel); and by oocytes maturing from metaphase I to metaphase II (Met I–Met II) or remaining at the metaphase II stage (Met II–Met II) during the second incubation period (right panel) in TCM 199 ({square}) and MEME ({blacksquare}). Numbers in each bar = number of oocytes analysed.

 
Comparing the effects of different media, it was found that during the first incubation, pyruvate uptake was similar in TCM 199 and MEME (Figure 2Go). In contrast, during the second incubation pyruvate uptake was higher in TCM 199 than in MEME, significantly so in fast maturers which had reached metaphase II during the previous incubation period (P = 0.007) (Figure 2Go). Oocytes that failed to mature continued to take up pyruvate and produce lactate at levels similar to oocytes which matured slowly (data not shown).

Lactate production by individual oocytes was lower than pyruvate uptake (Figure 2Go). In MEME, lactate production during the first incubation was significantly lower for fast maturers than for slow maturers, i.e. oocytes which had only reached metaphase I (P = 0.02). During the second incubation period, lactate production was significantly lower for slow than for fast maturers (P = 0.04). In TCM 199, lactate production was similar in the first and second maturation period, irrespective of whether oocytes were maturing quickly or slowly.

By assessing the maturational stage of the oocyte at the beginning and end of each incubation period, it was possible to correlate substrate uptake/production with a particular cellular event occurring during maturation. Pyruvate uptake was less during polar body extrusion than GVBD in both media, significantly so in MEME (P < 0.05, Figure 3Go). There was no significant difference in pyruvate uptake between the two media during GVBD or polar body extrusion (Figure 3Go). However, when oocytes that had already completed maturation and extruded their first polar body during the first culture period were cultured for a further 24 h, pyruvate uptake was significantly greater for those in TCM 199 than in MEME (P < 0.01, Figure 3Go). In TCM 199 there was no significant difference in the amount of lactate produced during GVBD, polar body extrusion or for oocytes remaining at metaphase II. However, when oocytes were matured in MEME, significantly less lactate was produced during polar body extrusion than during GVBD (P < 0.01, Figure 3Go).



View larger version (17K):
[in this window]
[in a new window]
 
Figure 3. Effect of stage of nuclear maturation on pyruvate uptake (left, pmol/oocyte/h) or lactate production (right) by oocytes cultured in TCM 199 ({square}) or MEME ({blacksquare}). GVBD = germinal vesicle breakdown; pb ext. = polar body extrusion; Met II–Met II = oocytes which remain at the metaphase II stage during a single incubation period (*P < 0.05). Numbers in each bar = number of oocytes analysed.

 
The possibility of using substrate uptake as a predictor of an oocyte’s competence to reach complete maturation was also evaluated. The metabolism during the first culture period of oocytes that completed maturation during the subsequent culture period was compared with that of oocytes that arrested at metaphase I. As there was no significant difference in the metabolism of oocytes undergoing GVBD and polar body extrusion under the two culture conditions (Figure 3Go), data were combined. Pyruvate uptake was similar for those oocytes that went on to complete maturation and those that arrested: 35.4 ± 2.6 (n = 7) versus 33.1 ± 2.3 (n = 6) pmol/oocyte/h respectively. Lactate production was lower for oocytes that went on to complete maturation during the second culture period: 4.7 ± 2.3 versus 12.1 ± 3.5 pmol/oocyte/h, but this difference was not statistically significant.


    Discussion
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 Acknowledgements
 References
 
This study is the first description of the non-invasive measurement of pyruvate uptake and lactate production by individual denuded human oocytes as they undergo nuclear maturation. Here we have shown, for the first time, that exposure of maturing human oocytes to two different commonly used commercial culture media (TCM 199 and MEME) for 48 h affects oocyte metabolism, specifically pyruvate uptake. More oocytes reached metaphase II during the first culture period in MEME compared with TCM 199, and the oocytes that matured more quickly had significantly lower lactate production than more slowly maturing oocytes. In TCM 199, rapidly maturing oocytes also had lower pyruvate uptake than slowly maturing oocytes. Pyruvate uptake and lactate production differed depending on the stage of nuclear maturation: pyruvate uptake and lactate production were greater during GVBD than polar body extrusion in MEME.

The maturation rates seen over a 48 h period are comparable with those achieved by others working with denuded, immature oocytes retrieved from women following superovulation (Janssenswillen et al., 1995Go; Farhi et al., 1997Go; Goud et al., 1998Go; Haberle et al., 1999Go). Significantly more oocytes reached metaphase II within 24 h in MEME than in TCM 199 (Figure 1Go). This could be important clinically, as earlier first polar body extrusion by mouse oocytes has been associated with improved developmental competence (van de Sandt et al., 1990Go). In general terms, MEME is a less complex medium than TCM 199. Both contain a similar range of inorganic salts, but MEME has a higher glucose concentration, fewer non-essential amino acids and a relatively small number of vitamins (Table IGo). TCM 199 has a lower glucose concentration, both essential and non-essential amino acids, a larger range of vitamins, purines and pyrimidines, and several other components such as cholesterol, glutathione and ribose (Table IGo). Amino acids are known to be beneficial for embryo development (Gardner and Lane, 1993Go; Steeves and Gardner, 1999bGo; Devreker et al., 2001Go) and oocyte maturation (Rose-Hellekant et al., 1998Go; Watson et al., 2000Go) in several species. However, certain amino acids are known to have a detrimental effect on hamster embryo development (Bavister and McKiernan, 1993Go). The different amino acid content between the two culture media may account for the difference in maturation rates seen in this study.

Other candidate factors for the relative inhibitory effect of TCM 199 on maturation of denuded immature ICSI oocytes are purines and purine precursors, both of which are present in this medium (Table IGo). Extensive studies on the maturation of cumulus-enclosed and denuded mouse oocytes have established the existence of a wide range of meiosis-inhibiting factors, including purines such as hypoxanthine (Downs et al., 1985Go), nucleosides such as adenosine (Eppig et al., 1985Go), and purine precursors such as glutamine, glycine and aspartic acid (Downs, 1998Go). The maturation-arresting action of these factors involve complex interactions between components in the media (for example glucose and pyruvate) and the oocyte and its companion cumulus cells. In the present study, several meiosis-arresting substrates, or their precursors, are present in TCM 199 that are not included in MEME, namely hypoxanthine, AMP, aspartic acid and glycine, which may explain the slower rate of maturation. However, levels of hypoxanthine in TCM 199 (2.2 µmol/l) are significantly lower those used to maintain meiotic arrest of denuded mouse oocytes (4 mmol/l) (Downs and Mastropolo, 1994Go), and such hypoxanthine-induced arrest can be completely reversed in the presence of 0.5 mmol/l pyruvate (which is also present in TCM 199). It is therefore unlikely that hypoxanthine per se is inhibiting maturation, although this does not preclude the possibility that the purines and purine precursors present in combination in TCM 199 may slow the rate of maturation.

Studies examining the metabolism of radiolabelled energy substrates during maturation of cumulus-free cow and cat oocytes (Rieger and Loskutoff, 1994Go; Steeves and Gardner, 1999aGo; Spindler et al., 2000Go) have shown that pyruvate is the predominant energy source. We have shown here that pyruvate uptake by maturing human oocytes is also high (Figures 2 and 3GoGo). Furthermore, levels of pyruvate uptake and lactate production by human oocytes maturing in vitro are consistent with previous studies in human embryos. The amount of pyruvate taken up throughout maturation is of a similar order of magnitude to that taken up by human oocytes (Leese et al., 1986Go) and embryos during their first cleavage divisions (Hardy et al., 1989Go; Gott et al., 1990Go; Conaghan et al., 1993Go; Turner et al., 1994Go; Devreker et al., 1998Go, 1999Go), but is higher than that of fertilized human zygotes following ICSI (Devreker et al., 2000Go).

Lactate was produced by maturing human oocytes in vitro at rates similar to those described previously for early human preimplantation embryos (Hardy et al., 1995Go; Devreker et al., 1998Go) but lower than that seen by Gott et al. (Gott et al., 1990Go). It has previously been proposed that lactate produced by preimplantation mouse and human embryos is derived from exogenous glucose (Gott et al., 1990Go). Levels of glucose in the two commercial media used here were high (Table IGo) compared with levels measured in fluid from the human Fallopian tube and uterus (Gardner et al., 1996Go), and glucose uptake by oocytes is negligible (Devreker et al., 2000Go). Studies using radiolabelled pyruvate as the sole energy source for 2-cell mouse embryos in vitro have demonstrated that lactate can be produced from pyruvate (Wales and Whittingham, 1970Go). Culture of early human embryos in medium containing pyruvate alone (Butcher et al., 1998Go) resulted in lactate production of a similar magnitude (~12 pmol/embryo/h) to that observed here (~10 pmol/oocyte/h, Figure 3Go). These data, in conjunction with high levels of lactate dehydrogenase in human embryos (Martin et al., 1993Go), suggest that the lactate produced could be derived from pyruvate.

During the first incubation, pyruvate uptake was similar in the two media (Figure 2Go). However, during the second incubation, pyruvate uptake was 30% lower in MEME than in TCM 199. Levels of glutamine are >4-fold higher in MEME compared with TCM 199 (Table IGo). Glutamine is metabolized by both maturing cow and cat oocytes (Rieger and Loskutoff, 1994Go; Steeves and Gardner, 1999aGo; Spindler et al., 2000Go). As both pyruvate and glutamine are tricarboxylic acid (TCA) cycle precursors, it can be hypothesized that the high levels of glutamine found in MEME may compete with pyruvate for entry into the TCA cycle, resulting in lower pyruvate uptake under these conditions. Alternatively, the presence of Tween 80 in TCM 199 could result in the oocyte membrane becoming more permeable with time, leading to higher pyruvate uptake during the second incubation.

The significant differences in pyruvate uptake between oocytes undergoing GVBD and those extruding their polar body when cultured in MEME are intriguing. Cyclic AMP (cAMP) is involved in the maintenance of meiosis in a number of species (Downs, 1995aGo; review) and arises from ATP by the action of adenylate cyclase. During spontaneous maturation in vitro, cAMP levels decrease in oocytes (Downs, 1995aGo), and this is associated with a decrease in ATP levels (Downs, 1995bGo). It is possible that once the oocyte is irreversibly committed to mature, cAMP is no longer required to maintain meiotic arrest, ATP requirements fall and pyruvate uptake decreases. Interestingly, pyruvate uptake by oocytes which failed to mature remained high throughout the 24 h period.

Maturation of human oocytes in vitro is accompanied by changes in the aggregation patterns of mitochondria (Sathananthan and Trounson, 2000Go; Wilding et al., 2001Go), which may reflect changing metabolic needs of the oocyte in preparation for fertilization. These changes in mitochondrial distribution may also account for the lower pyruvate uptake that was observed during later stages of nuclear maturation.

This work has shown for the first time that it is possible to measure pyruvate uptake and lactate production by individual, maturing human oocytes non-invasively. It also demonstrates that the metabolism of human oocytes can be significantly influenced by both the composition of the in-vitro culture medium and the cellular event taking place within the oocyte nucleus. The fact that the culture environment affects metabolism during human oocyte maturation suggests that the choice of culture medium for clinical IVM could be critical for embryonic and possibly fetal health. Further work is needed to investigate how substrate utilisation by maturing oocytes relates to subsequent development.


    Acknowledgements
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 Acknowledgements
 References
 
The authors are grateful to members of the IVF Unit for their help. The authors would like to thank J.Stark for help with the statistical analysis. This study was funded by Wellbeing.


    Notes
 
1 To whom correspondence should be addressed. E-mail: l.ruth.roberts{at}ic.ac.uk Back


    References
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 Acknowledgements
 References
 
Bavister, B.D. and McKiernan, S.H. (1993) Regulation of hamster embryo development in vitro by amino acids. In Bavister, B.D. (ed.) Preimplantation Embryo Development. Springer-Verlag, New York, USA, pp. 57–72.

Biggers, J.D., Whittingham, D.G. and Donahue, R.P. (1967) The pattern of energy metabolism in the mouse oocyte and zygote. Proc. Natl Acad. Sci. USA, 58, 560–567.[ISI][Medline]

Butcher, L., Coates, A., Martin, K.L., Rutherford, A.J. and Leese, H.J. (1998) Metabolism of pyruvate by the early human embryo. Biol. Reprod., 58, 1054–1056.[Abstract]

Conaghan, J., Hardy, K., Handyside, A.H., Winston, R.M. and Leese, H.J. (1993) Selection criteria for human embryo transfer: a comparison of pyruvate uptake and morphology. J. Assist. Reprod. Genet., 10, 21–30.[ISI][Medline]

Dawson, K.J., Conaghan, J., Ostera, G.R., Winston, R.M. and Hardy, K. (1995) Delaying transfer to the third day post-insemination, to select non-arrested embryos, increases development to the fetal heart stage. Hum. Reprod., 10, 177–182.[Abstract]

Devreker, F., Winston, R.M. and Hardy, K. (1998) Glutamine improves human preimplantation development in vitro. Fertil. Steril., 69, 293–299.[ISI][Medline]

Devreker, F., Van den Bergh, M., Biramane, J., Winston, R.L., Englert, Y. and Hardy, K. (1999) Effects of taurine on human embryo development in vitro. Hum. Reprod., 14, 2350–2356.[Abstract/Free Full Text]

Devreker, F., Hardy, K., Van den Bergh, M., Winston, J., Biramane, J. and Englert, Y. (2000) Noninvasive assessment of glucose and pyruvate uptake by human embryos after intracytoplasmic sperm injection and during the formation of pronuclei. Fertil. Steril., 73, 947–954.[ISI][Medline]

Devreker, F., Hardy, K., Van den Bergh, M., Vannin, A.S., Emiliani, S. and Englert, Y. (2001) Amino acids promote human blastocyst development in vitro. Hum. Reprod., 16, 749–756.[Abstract/Free Full Text]

Doherty, A.S., Mann, M.R., Tremblay, K.D., Bartolomei, M.S. and Schultz, R.M. (2000) Differential effects of culture on imprinted H19 expression in the preimplantation mouse embryo. Biol. Reprod., 62, 1526–1535.[Abstract/Free Full Text]

Downs S.M. (1995a) Ovulation 2: Control of the resumption of meiotic maturation in mammalian oocytes. In Grudzinskas, J.G. and Yovich, J.L. (eds) Gametes—The Oocyte. Cambridge University Press, Cambridge, UK, pp. 150–192.

Downs, S.M. (1995b) The influence of glucose, cumulus cells, and metabolic coupling on ATP levels and meiotic control in the isolated mouse oocyte. Dev. Biol., 167, 502–512.[ISI][Medline]

Downs, S.M. (1998) Precursors of the purine backbone augment the inhibitory action of hypoxanthine and dibutyryl cAMP on mouse oocyte maturation. J. Exp. Zool., 282, 376–384.[ISI][Medline]

Downs, S.M. and Mastropolo, A.M. (1994) The participation of energy substrates in the control of meiotic maturation in murine oocytes. Dev. Biol., 162, 154–168.[ISI][Medline]

Downs, S.M., Coleman, D.L., Ward-Bailey, P.F. and Eppig, J.J. (1985) Hypoxanthine is the principal inhibitor of murine oocyte maturation in a low molecular weight fraction of porcine follicular fluid. Proc. Natl Acad. Sci. USA, 82, 454–458.[Abstract]

Edirisinghe, W.R., Junk, S.M., Matson, P.L. and Yovich, J.L. (1997) Birth from cryopreserved embryos following in-vitro maturation of oocytes and intracytoplasmic sperm injection. Hum. Reprod., 12, 1056–1058.[ISI][Medline]

Edwards, R.G. (1965) Maturation in vitro of mouse, sheep, cow, pig, rhesus monkey and human ovarian oocytes. Nature, 208, 349–351.[ISI][Medline]

Eppig, J.J., Ward-Bailey, P.F. and Coleman, D.L. (1985) Hypoxanthine and adenosine in murine ovarian follicular fluid: concentrations and activity in maintaining oocyte meiotic arrest. Biol. Reprod., 33, 1041–1049.[Abstract]

Fagbohun, C.F. and Downs, S.M. (1992) Requirement for glucose in ligand-stimulated meiotic maturation of cumulus cell-enclosed mouse oocytes. J. Reprod. Fertil., 96, 681–697.[Abstract]

Farhi, J., Nahum, H., Zakut, H. and Levran, D. (1997) Incubation with sperm enhances in vitro maturation of the oocyte from the germinal vesicle to the M2 stage. Fertil. Steril., 68, 318–322.[ISI][Medline]

Gardner, D.K. and Lane, M. (1993) Amino acids and ammonium regulate mouse embryo development in culture. Biol. Reprod., 48, 377–385.[Abstract]

Gardner, D.K., Lane, M., Calderon, I. and Leeton, J. (1996) Environment of the preimplantation human embryo in vivo: metabolite analysis of oviduct and uterine fluids and metabolism of cumulus cells. Fertil. Steril., 65, 349–353.[ISI][Medline]

Gott, A.L., Hardy, K., Winston, R.M. and Leese, H.J. (1990) Non-invasive measurement of pyruvate and glucose uptake and lactate production by single human preimplantation embryos. Hum. Reprod., 5, 104–108.[Abstract]

Goud, P.T., Goud, A.P., Qian, C., Laverge, H., Van der Elst, J., De Sutter, P. and Dhont, M. (1998) In-vitro maturation of human germinal vesicle stage oocytes: role of cumulus cells and epidermal growth factor in the culture medium. Hum. Reprod., 13, 1638–1644.[Abstract]

Haberle, M., Scheurer, P., Lauerer, K., Fischer, M. and Hohl, M.K. (1999) Are cumulus cells necessary for the spontaneous maturation of germinal vesicle-stage oocytes to metaphase II. J. Assist. Reprod. Genet., 16, 329–331.[ISI][Medline]

Hardy, K., Hooper, M.A., Handyside, A.H., Rutherford, A.J., Winston, R.M. and Leese, H.J. (1989) Non-invasive measurement of glucose and pyruvate uptake by individual human oocytes and preimplantation embryos. Hum. Reprod., 4, 188–191.[Abstract]

Hardy, K., Robinson, F.M., Paraschos, T., Wicks, R., Franks, S. and Winston, R.M. (1995) Normal development and metabolic activity of preimplantation embryos in vitro from patients with polycystic ovaries. Hum. Reprod., 10, 2125–2135.[Abstract]

Ho, Y., Wigglesworth, K., Eppig, J.J. and Schultz, R.M. (1995) Preimplantation development of mouse embryos in KSOM: augmentation by amino acids and analysis of gene expression. Mol. Reprod. Dev., 41, 232–238.[ISI][Medline]

Janssenswillen, C., Nagy, Z.P. and Van Steirteghem, A. (1995) Maturation of human cumulus-free germinal vesicle-stage oocytes to metaphase II by coculture with monolayer Vero cells. Hum. Reprod., 10, 375–378.[Abstract]

Khosla, S., Dean, W., Reik, W. and Feil, R. (2001) Culture of preimplantation embryos and its long-term effects on gene expression and phenotype. Hum. Reprod. Update, 7, 419–427.[Abstract/Free Full Text]

Khurana, N.K. and Niemann, H. (2000) Energy metabolism in preimplantation bovine embryos derived in vitro or in vivo. Biol. Reprod., 62, 847–856.[Abstract/Free Full Text]

Kim, B.K., Lee, S.C., Kim, K.J., Han, C.H. and Kim, J.H. (2000) In vitro maturation, fertilization, and development of human germinal vesicle oocytes collected from stimulated cycles. Fertil. Steril., 74, 1153–1158.[ISI][Medline]

Leese, H.J. and Barton, A.M. (1985) Production of pyruvate by isolated mouse cumulus cells. J. Exp. Zool., 234, 231–236.[ISI][Medline]

Leese, H.J., Hooper, M.A., Edwards, R.G. and Ashwood-Smith, M.J. (1986) Uptake of pyruvate by early human embryos determined by a non-invasive technique. Hum. Reprod., 1, 181–182.[Abstract]

Leese, H.J., Donnay, I. and Thompson, J.G. (1998) Human assisted conception: a cautionary tale. Lessons from domestic animals. Hum. Reprod., 13 (Suppl. 4), 184–202.[Medline]

McEvoy, T.G., Robinson, J.J. and Sinclair, K.D. (2001) Developmental consequences of embryo and cell manipulation in mice and farm animals. Reproduction, 122, 507–518.[Abstract/Free Full Text]

Martin, K.L., Hardy, K., Winston, R.M. and Leese, H.J. (1993) Activity of enzymes of energy metabolism in single human preimplantation embryos. J. Reprod. Fertil., 99, 259–266.[Abstract]

Nagy, Z.P., Cecile, J., Liu, J., Loccufier, A., Devroey, P. and Van Steirteghem, A. (1996) Pregnancy and birth after intracytoplasmic sperm injection of in vitro matured germinal-vesicle stage oocytes: case report. Fertil. Steril., 65, 1047–1050.[ISI][Medline]

Niemann, H. and Wrenzycki, C. (2000) Alterations of expression of developmentally important genes in preimplantation bovine embryos by in vitro culture conditions: implications for subsequent development. Theriogenology, 53, 21–34.[ISI][Medline]

Pincus, G.P. and Enzmann, E.V. (1935) The comparative behaviour of mammalian eggs in vivo and in vitro. I. The activation of ovarian eggs. J. Exp. Med., 62, 665–675.

Rieger, D. and Loskutoff, N.M. (1994) Changes in the metabolism of glucose, pyruvate, glutamine and glycine during maturation of cattle oocytes in vitro. J. Reprod. Fertil., 100, 257–262.[Abstract]

Rose, T.A. and Bavister, B.D. (1992) Effect of oocyte maturation medium on in vitro development of in vitro fertilized bovine embryos. Mol. Reprod. Dev., 31, 72–77.[ISI][Medline]

Rose-Hellekant, T.A., Libersky-Williamson, E.A. and Bavister, B.D. (1998) Energy substrates and amino acids provided during in vitro maturation of bovine oocytes alter acquisition of developmental competence. Zygote, 6, 285–294.[ISI][Medline]

Sathananthan, A.H. and Trounson, A.O. (2000) Mitochondrial morphology during preimplantational human embryogenesis. Hum. Reprod., 15 (Suppl. 2), 148–159.[Medline]

Spindler, R.E., Pukazhenthi, B.S. and Wildt, D.E. (2000) Oocyte metabolism predicts the development of cat embryos to blastocyst in vitro. Mol. Reprod. Dev., 56, 163–171.[ISI][Medline]

Steeves, T.E. and Gardner, D.K. (1999a) Metabolism of glucose, pyruvate, and glutamine during the maturation of oocytes derived from pre-pubertal and adult cows. Mol. Reprod. Dev., 54, 92–101.[ISI][Medline]

Steeves, T.E. and Gardner, D.K. (1999b) Temporal and differential effects of amino acids on bovine embryo development in culture. Biol. Reprod., 61, 731–740.[Abstract/Free Full Text]

Trounson, A., Anderiesz, C. and Jones, G. (2001) Maturation of human oocytes in vitro and their developmental competence. Reproduction, 121, 51–75.[Abstract/Free Full Text]

Tucker, M.J., Wright, G., Morton, P.C. and Massey, J.B. (1998) Birth after cryopreservation of immature oocytes with subsequent in vitro maturation. Fertil. Steril., 70, 578–579.[ISI][Medline]

Turner, K., Martin, K.L., Woodward, B.J., Lenton, E.A. and Leese, H.J. (1994) Comparison of pyruvate uptake by embryos derived from conception and non-conception natural cycles. Hum. Reprod., 9, 2362–2366.[Abstract]

van de Sandt, J.J., Schroeder, A.C. and Eppig, J.J. (1990) Culture media for mouse oocyte maturation affect subsequent embryonic development. Mol. Reprod. Dev., 25, 164–171.[ISI][Medline]

Wales, R.G. and Whittingham, D.G. (1970) Metabolism of specifically labelled pyruvate by mouse embryos during culture from the two-cell stage to the blastocyst. Aust. J. Biol. Sci., 23, 877–887.[ISI][Medline]

Watson, A.J., De Sousa, P., Caveney, A., Barcroft, L.C., Natale, D., Urquhart, J. and Westhusin, M.E. (2000) Impact of bovine oocyte maturation media on oocyte transcript levels, blastocyst development, cell number, and apoptosis. Biol. Reprod., 62, 355–364.[Abstract/Free Full Text]

Wilding, M., Dale, B., Marino, M., di Matteo, L., Alviggi, C., Pisaturo, M.L., Lombardi, L. and De Placido, G. (2001) Mitochondrial aggregation patterns and activity in human oocytes and preimplantation embryos. Hum. Reprod., 16, 909–917.[Abstract/Free Full Text]

Young, L.E., Sinclair, K.D. and Wilmut, I. (1998) Large offspring syndrome in cattle and sheep. Rev. Reprod., 3, 155–163.[Abstract/Free Full Text]

Submitted on January 8, 2002; resubmitted on March 19, 2002; accepted on June 12, 2002.